Drug-induced diarrhea

被引:37
作者
Abraham B. [1 ]
Sellin J.H. [1 ]
机构
[1] University of Texas Medical Branch, Galveston, TX 77555-0764
关键词
Diarrhea; Orlistat; Loperamide; Chenodeoxycholic Acid; Motilin;
D O I
10.1007/s11894-007-0044-x
中图分类号
学科分类号
摘要
Many drugs have been known to cause diarrhea, although their mechanism of action has not been well described. The gastrointestinal tract may become dysregulated when exposed to a drug that could disrupt mechanisms controlling mucosal permeability, transport, motility, and gut metabolism. This review examines the mechanism by which drugs induce diarrhea within the broad classification of watery, inflammatory, and fatty characteristics of the stool. Treatment may vary depending on this classification and usually includes withdrawal of the offending drug. However, in some cases, diarrhea may resolve with continued use or through nonspecific agents, such as Lomotil (Pfizer, New York, NY) or loperamide. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:365 / 372
页数:7
相关论文
共 47 条
[21]  
Andersson K.E., Current concepts in the treatment of disorders of micturition, Drugs, 35, (1988)
[22]  
Bateman D.N., Gastrointestinal disorders, Textbook of adverse drug reactions, pp. 230-244, (1991)
[23]  
Nayak B., Burman K., Thyrotoxicosis and thyroid storm, Endocrinol Metab Clin N Am, 35, pp. 663-686, (2006)
[24]  
Wasan S.M., Sellin J.H., Vassilopoulou-Sellin R., The gastrointestinal tract and liver in thyrotoxicosis, Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, pp. 589-594, (2005)
[25]  
Wegener M., Wedmann B., Langhoff T., Et al., Effect of hyperthyroidism on the transit of a caloric sotid-liquid meal through the stomach, the small intestine, and the colon in man, J Clin Endocrinol Metab, 75, pp. 745-749, (1992)
[26]  
Gervasio J.M., Diarrhea and constipation, Drug-Induced Diseases: Prevention, Detection, and Management, pp. 501-514, (2005)
[27]  
Parfitt J.R., Driman D.K., Pathological effects of drugs on the gastrointestinal tract: A review, Human Pathol, 38, pp. 527-536, (2007)
[28]  
Rodemann J.F., Dubberke E.R., Reske K.A., Et al., Incidence of Clostridium difficile infection in inflammatory bowel disease, Clin Gastroenterol Hepatol, 5, pp. 339-344, (2007)
[29]  
Issa M., Vijayapal A., Graham M.B., Et al., Impact of Clostridium difficile on inflammatory bowel disease, Clin Gastroenterol Hepatol, 5, pp. 345-351, (2007)
[30]  
D'Arcy P.F., Griffin J.P., Iatrogenic Diseases, (1986)